A systematic review of adherence-enhancing interventions in adolescents taking long-term medicines.
OBJECTIVE
To assess the effectiveness of adherence-enhancing interventions (AEIs) aimed at adolescents (10-19-year-olds).


METHODS
An extensive search of seven bibliographic databases was conducted at the end of 2009 to identify comparative studies evaluating AEIs targeting adolescents. Data describing study characteristics and intervention effects on adherence to medicines or health outcomes were extracted and summarized using qualitative and quantitative methods.


RESULTS
A total of 17 AEIs were identified: 12 studies (70%) were conducted in the United States, 10 (59%) included adolescents with type 1 diabetes mellitus, and 14 (82%) considered the developmental tasks of adolescence. In all, 12 AEIs successfully improved outcome measures. Features of successful interventions included targeting AEIs to a narrow age range, including family in type 1 diabetes mellitus management, and improving access to care. Poor quality and underpowered studies limit the inferences drawn from this review.


CONCLUSIONS
More diverse and robust studies are needed to identify strategies to help adolescents manage medicines.
School of Pharmacy, Division of Social Research in Medicines and Health, The University of Nottingham, Nottingham, UK. Ndeshi.Salema@nottingham.ac.uk
Nde-Eshimuni M
NE
Salema
Rachel A
RA
Elliott
Cris
C
Glazebrook
D000293:Adolescent; D000294:Adolescent Behavior / Q000523:psychology*; D001294:Attitude to Health; D002648:Child; D002652:Child Behavior / Q000523:psychology; D002908:Chronic Disease / Q000188:drug therapy*; D003920:Diabetes Mellitus / Q000188:drug therapy; D019317:Evidence-Based Medicine; D019983:Guideline Adherence; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D010353:Patient Education as Topic / Q000379:methods*; D011785:Quality Assurance, Health Care / Q000458:organization & administration; D017010:Reminder Systems / Q000706:statistics & numerical data*; D012959:Socioeconomic Factors; D016903:Drug Monitoring
D007004:Hypoglycemic Agents